Last reviewed · How we verify

Midazolam and GDC-0853

Genentech, Inc. · Phase 1 active Small molecule

At a glance

Generic nameMidazolam and GDC-0853
SponsorGenentech, Inc.
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results